© Copyright 2025 American Medical Association. All rights reserved.
A laboratory test designated by CPT® Code 80351 is utilized to measure the presence of synthetic cannabinoids in biological samples such as urine, saliva, or blood. Synthetic cannabinoids are chemically engineered substances that mimic the effects of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. Commonly known as 'spice' or 'K2,' these substances are often marketed under various names, including 'herbal incense,' 'potpourri,' or 'legal' marijuana. Unlike natural cannabis, synthetic cannabinoids are designed to interact with the same receptors in the central nervous system as THC, leading to similar psychoactive effects. However, they are associated with a higher risk of adverse reactions, including anxiety, agitation, and hallucinations. These designer drugs are categorized into three main classes: classical cannabinoids (such as HU-210), cyclohexylphenols, and aminoalkylindoles. The chemical structures of synthetic cannabinoids are frequently altered to evade detection in standard drug tests, making them a challenge for accurate identification. It is important to note that synthetic cannabinoids will not be identified in immunoassay tests that are typically used for THC detection. The collection of samples for testing involves specific methods: a blood sample is obtained through a separately reportable venipuncture, a urine sample can be collected via random void or catheterization, and saliva is gathered using a swab or in a sample cup. The testing methodologies employed include liquid chromatography-tandem mass spectrometry for blood and saliva samples, while urine samples are initially screened using enzyme-linked immunosorbent assay and subsequently confirmed with high-performance liquid chromatography-tandem mass spectrometry. For coding purposes, CPT® Code 80350 is applicable for testing 1-3 synthetic cannabinoids, while CPT® Code 80351 is specifically designated for the analysis of 4-6 synthetic cannabinoid compounds, and CPT® Code 80352 is used when testing for 7 or more synthetic cannabinoids.
© Copyright 2025 Coding Ahead. All rights reserved.
The laboratory test associated with CPT® Code 80351 is indicated for the detection and measurement of synthetic cannabinoids in patients who may be experiencing symptoms related to their use. The following conditions or situations may warrant the performance of this test:
The procedure for testing synthetic cannabinoids as per CPT® Code 80351 involves several key steps, which are outlined below:
After the completion of the testing procedure, the results are analyzed and interpreted by qualified laboratory personnel. The findings are then reported to the requesting healthcare provider, who will use the information to guide clinical decision-making. Depending on the results, further evaluation or intervention may be necessary for the patient. It is important to consider that the detection of synthetic cannabinoids may have implications for treatment plans, legal matters, or employment status. Patients may be advised on the potential effects of synthetic cannabinoids and the importance of avoiding their use, especially in the context of mental health and safety.
Short Descr | CANNABINOIDS SYNTHETIC 4-6 | Medium Descr | DRUG SCREENING CANNABINOIDS SYNTHETIC 4-6 | Long Descr | Cannabinoids, synthetic; 4-6 | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x) | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | 1 |
Date
|
Action
|
Notes
|
---|---|---|
2015-01-01 | Added | Added |